ロード中...
Once-Monthly Subcutaneously Administered Risperidone in the Treatment of Schizophrenia: Patient Considerations
Adherence to antipsychotic medications is a major challenge in schizophrenia. Long-acting injectable antipsychotics have been shown to offer advantages over oral formulations. A new extended release formulation of risperidone for subcutaneous injection was developed to address issues of non-adherenc...
保存先:
| 出版年: | Patient Prefer Adherence |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7053417/ https://ncbi.nlm.nih.gov/pubmed/32184570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S192418 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|